Results 251 to 260 of about 513,616 (274)
M0: Causes and Consequences [PDF]
, 1993 This paper analyses four aspects of the determination and effects of M0 using annual, quarterly and monthly data. First it analyses the issue of the correct scale variable for determining M0. A combination of survey evidence and statistical tests indicate that retail sales is the most appropriate scale variable to use in looking at M0.
Francis Breedon, Paul Fisher
openaire
Some of the next articles are maybe not open access.
Related searches:
Related searches:
American Journal of Clinical Oncology, 1996
All patients with M0 carcinoma of the lung regardless of the histology, exclusive of Pancoast tumors referred to the same radiation oncology team from 1988 to 1992 were identified. They were 101 patients; 16 of whom were postoperative. To determine the patterns of radiation therapy and results, these cases were analyzed according to the radiation dose ...
R, Abadir, T L, Demmy
openaire +2 more sources
All patients with M0 carcinoma of the lung regardless of the histology, exclusive of Pancoast tumors referred to the same radiation oncology team from 1988 to 1992 were identified. They were 101 patients; 16 of whom were postoperative. To determine the patterns of radiation therapy and results, these cases were analyzed according to the radiation dose ...
R, Abadir, T L, Demmy
openaire +2 more sources
[A case report of AML M0:CD7, 33 (+) AML M0 case initially presented with cervical lymphadenopathy].
[Rinsho ketsueki] The Japanese journal of clinical hematology, 1992A 59-year-old man was admitted because of generalized lymphadenopathy with fever and vomiting. His peripheral blood showed leukocytosis with a WBC of 93,500/microliters, and the bone marrow picture revealed a predominance of blast cells. The blasts were negative for peroxidase, alpha-naphthyl butyrate esterase and PAS, and had the phenotype of CD 7, 13
J, Horiguchi +6 more
openaire +1 more source
Aims of Combined Modality Therapy in Rectal Cancer (M0)
2014OPTIMIZING THE COST/BENEFIT RATIO OF TREATMENT: Evidence Based The aim of a cancer treatment is always to achieve the maximum of cure rate with a minimum of toxicity and best quality of life at an acceptable cost for the society. It is always a multifactorial challenge depending on the patient, the tumor, the doctor, and the society cultural and ...
J P, Gerard +3 more
openaire +2 more sources
Leucémie aiguë myéloblastique peu différenciée (M0)
Revue Française des Laboratoires, 2002Michèle Imbert, Hélène Jouault
openaire +1 more source
FORCE Interim report (M0-M6), Year 2
2021The work herein described is the first interim report of the 2° year of activity in the frame of the contract No. W911NF1920253 between the US ARMY ACC-APC-RTP W911NF and the National Research Council of Italy, Institute of Science and Technology of Ceramics (CNR-ISTEC). The contract was initiated on August 2019 with Dr.
openaire +1 more source